Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-06-29 @ 2:55 AM
Study NCT ID:
NCT04139434
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-24
First Post:
2019-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML
Sponsor:
Newave Pharmaceutical Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LP-108P
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None